Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrinogen silencer-binding protein (FSBP) is a nuclear transcription factor that down-regulates expression of the gamma chain of fibrinogen, a plasma glycoprotein essential for coagulation. FSBP is implicated in feedback regulation of inflammatory and cytokine signaling pathways, particularly the JAK/STAT axis. In cancer biology, FSBP acts as a suppressor of tumor migration and metastasis by inhibiting the JNK pathway. There is evolutionary conservation between FSBP in humans and the Drosophila gene Apontic (Apt), with functional relevance in developmental biology and cell differentiation. FSBP may have roles in diseases such as cancer and cardiovascular conditions related to fibrinogen levels
Transcriptional repression via DNA binding and interaction with transcriptional machinery\nSuppression of JNK signaling pathway to inhibit metastasis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrinogen silencer-binding protein (FSBP).